Summary
- Current Price
- As of today, CUVL price is $6.52, up +3.82% on
- Current Price All-Time High
- CUVL price is currently -79.26% below its historical high of $31.44 set on
- Revenue
- CUVL current annual revenue is $63.71M, up +3.54% year-over-year
- Next Earnings
- As of today, the next earnings release for CUVL has not been scheduled
Profile
| Metric | Value |
|---|---|
| Full Name | Clinuvel Pharmaceuticals Limited |
| Ticker | NASDAQ: CUVL |
| Exchange | NASDAQ |
| Sector | Healthcare |
| Industry | Biotechnology |
| Country | Australia |
| IPO | |
| Indexes | Not included |
| Website | clinuvel.com |
| Employees | - |
Key Metrics
| Metric | Value | Date |
|---|---|---|
| $6.52 | ||
| Price, 1D Change | +3.82% | |
| - | ||
| 0.50% | ||
| - | ||
| 0.53 | ||
| $63.71M | ||
| Revenue, 1Y Change | +3.54% | |
| $0.45 | ||
| EPS, 1Y Change | -2.60% |
Chart
SUGGESTED SERIES
Events
| Metric | Value | Date |
|---|---|---|
| Next Earnings | N/A | |
| Last Qtr. Earnings | N/A | |
| Last Ann. Earnings | N/A | |
| Last Ex-Dividend | $0.03 | |
| Next Ex-Dividend | $0.04 | |
| Last Split | N/A | N/A |
| Next Split | N/A | N/A |
| Last Ticker Change | N/A | N/A |
| Next Ticker Change | N/A | N/A |
🔒 Log In To Unlock Full Data
Estimates
| Metric | Value | Date |
|---|---|---|
| $0.45 | ||
| EPS Estimate | - | N/A |
| EPS Est. Change | - | N/A |
| $63.71M | ||
| Revenue Estimate | - | N/A |
| Revenue Est. Change | - | N/A |
| $6.52 | ||
| Price Target | - | - |
| Price Tgt. Change | - | - |
🔒 Log In To Unlock Full Data
EPS
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| - | $0.46 | - | |
| - | $0.47 | - | |
| - | $0.45 | - |
Revenue
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| - | $57.78M | - | |
| - | $61.54M | - | |
| - | $63.71M | - |
🔒 Log In To Unlock Full Data
Performance
| Metric | Value | Date |
|---|---|---|
| -7.52% | ||
| -45.48% | ||
| - | ||
| - | ||
| +3.54% | ||
| +20.94% | ||
| -2.60% | ||
| +13.99% |
🔒 Log In To Unlock Full Data
Technicals
| Metric | Value | Date |
|---|---|---|
| $6.52 | ||
| $7.27 | ||
| $6.97 | ||
| $7.14 | ||
| $6.87 | ||
| -$0.17 | ||
| 0.53 | ||
| $0.45 | ||
| 45.32 | ||
| 86.30% |
Dividends
| Metric | Value | Date |
|---|---|---|
| $0.03 | ||
| Upcoming | $0.04 | |
| 0.50% | ||
| $0.03 | ||
| $1.70M | ||
| 7.39% |
🔒 Log In To Unlock Full Data
Income & Profitability
| Metric | Value | Date |
|---|---|---|
| $63.71M | ||
| $0.45 | ||
| $53.00M | ||
| 83.18% | ||
| $27.52M | ||
| 43.19% | ||
| $22.98M | ||
| 36.07% | ||
| $28.19M |
🔒 Log In To Unlock Full Data
Financial Health
| Metric | Value | Date |
|---|---|---|
| 0.01 | ||
| 14.81 | ||
| 14.45 | ||
| - | ||
| - | N/A | |
| - |
Valuations
| Metric | Value | Date |
|---|---|---|
| - | ||
| - | ||
| - | ||
| - | ||
| - | N/A |
Balance Sheet
| Metric | Value | Date |
|---|---|---|
| $189.05M | ||
| $174.62M | ||
| $205.17M | ||
| $197.19M | ||
| $16.12M | ||
| $13.31M | ||
| $1.34M | ||
| $269.20K | ||
| $886.30K |
Expenses
| Metric | Value | Date |
|---|---|---|
| $40.73M | ||
| $25.48M | ||
| $10.72M | ||
| $13.22M | ||
| $667.80K | ||
| $0.00 | ||
| $9.31M |
Cash Flow
| Metric | Value | Date |
|---|---|---|
| $25.01M | ||
| -$26.51M | ||
| -$1.87M | ||
| $1.09M | ||
| $23.93M |
Recent analyst updates
No data
Analyst sentiment
No data
Institutional ownership
No data
Screeners with CUVL
FAQ
- What is the ticker symbol for Clinuvel Pharmaceuticals Limited?
- The ticker symbol for Clinuvel Pharmaceuticals Limited is NASDAQ:CUVL
- Does Clinuvel Pharmaceuticals Limited pay dividends?
- Yes, Clinuvel Pharmaceuticals Limited pays dividends. The last payment was $0.03, with an ex-dividend date on September 8, 2025
- What sector is Clinuvel Pharmaceuticals Limited in?
- Clinuvel Pharmaceuticals Limited is in the Healthcare sector
- What industry is Clinuvel Pharmaceuticals Limited in?
- Clinuvel Pharmaceuticals Limited is in the Biotechnology industry
- What country is Clinuvel Pharmaceuticals Limited based in?
- Clinuvel Pharmaceuticals Limited is headquartered in Australia
- When did Clinuvel Pharmaceuticals Limited go public?
- Clinuvel Pharmaceuticals Limited initial public offering (IPO) was on July 13, 2026
- Is Clinuvel Pharmaceuticals Limited in the S&P 500?
- No, Clinuvel Pharmaceuticals Limited is not included in the S&P 500 index
- Is Clinuvel Pharmaceuticals Limited in the NASDAQ 100?
- No, Clinuvel Pharmaceuticals Limited is not included in the NASDAQ 100 index
- Is Clinuvel Pharmaceuticals Limited in the Dow Jones?
- No, Clinuvel Pharmaceuticals Limited is not included in the Dow Jones index
- When does Clinuvel Pharmaceuticals Limited report earnings?
- The date for Clinuvel Pharmaceuticals Limited's next earnings report has not been announced yet
Data Sources & References
- CUVL Official Website www.clinuvel.com
- CUVL Profile on Yahoo Finance finance.yahoo.com/quote/CUVL
- CUVL Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/cuvl